首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai
【24h】

Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in Mumbai

机译:孟买一家三级护理实验室的耐碳青霉烯肠杆菌科的分子表征

获取原文
获取原文并翻译 | 示例
       

摘要

Carbapenem-hydrolyzing beta-lactamases are increasingly reported worldwide, leading to therapeutic failure. In an era where the drug development pipeline is stagnant, it is crucial to preserve current classes of antibiotics to help fight against infection caused by multidrug-resistant organisms (MDROs), by practicing a rational approach for the use of antibiotics. Identifying the mechanisms of resistance gives us much needed insights in this field. A total of 113 consecutive, non-duplicate carbapenem-resistant clinical isolates were collected from July to December 2012. These isolates were subjected to the modified Hodge test (MHT) for phenotypic detection of carbapenemases, an inhibitor-based test employing EDTA for the detection of metallo-beta-lactamase (MBL), and phenylboronic acid for the detection of Klebsiella pneumoniae carbapenemase (KPC). A multiplex polymerase chain reaction (PCR) assay that characterized the five most predominant carbapenemases (bla (NDM), bla (OXA), bla (VIM), bla (IMP), bla (KPC)) was designed. The 113 isolates consisted of Klebsiella spp. (46), Enterobacter spp. (32), Escherichia coli (31), Citrobacter spp. (2), Proteus spp. (1), and Morganella spp. (1). bla (NDM-1) was the most prevalent carbapenemase and accounted for 75.22 % (85/113) of the isolates. This was followed by bla (OXA) [4.42 % (n = 5)]. 18.5 % (21/113) of the isolates possessed dual carbapenemase genes. 98.9 % concordance was observed between the phenotypic tests and the molecular tests for the detection of MBL. In conclusion, patients infected with resistant bacteria require early appropriate antimicrobial treatment for good clinical outcome. Thus, identifying the resistant mechanisms of suspected pathogens becomes crucial. Also, the high incidence of plasmid-mediated bla (NDM-1) calls for the implementation of strict infection control and contact isolation precautions in order to prevent the spread of these organisms.
机译:碳青霉烯水解β-内酰胺酶在世界范围内越来越多地报道,导致治疗失败。在药物开发渠道停滞的时代,至关重要的是,通过实践合理的抗生素使用方法,保留当前种类的抗生素,以帮助抵抗由多药耐药生物(MDRO)引起的感染。确定抗药性机制为我们提供了该领域急需的见解。从2012年7月至2012年12月,总共收集了113份连续的,非重复的对碳青霉烯抗药性的临床分离株。这些分离株经过改良的Hodge测试(MHT)进行碳青霉烯酶的表型检测。 β-内酰胺酶(MBL)和苯基硼酸的检测用于肺炎克雷伯菌肺炎克雷伯菌(KPC)的检测。设计了表征五种最主要的碳青霉烯酶(bla(NDM),bla(OXA),bla(VIM),bla(IMP),bla(KPC))的多重聚合酶链反应(PCR)分析。 113个分离株由克雷伯氏菌属组成。 (46),肠杆菌属。 (32),大肠杆菌(31),柠檬酸杆菌属。 (2),变形杆菌属。 (1)和Morganella spp。 (1)。 bla(NDM-1)是最流行的碳青霉烯酶,占分离株的75.22%(85/113)。其次是bla(OXA)[4.42%(n = 5)]。分离株中有18.5%(21/113)具有双重碳青霉烯酶基因。在表型测试和分子测试之间,MBL的检测一致性达到98.9%。总之,感染抗药性细菌的患者需要尽早进行适当的抗菌治疗,以取得良好的临床效果。因此,确定可疑病原体的耐药机制变得至关重要。同样,质粒介导的bla(NDM-1)的高发生率要求实施严格的感染控制和接触隔离预防措施,以防止这些生物传播。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号